Generic blood drug put to the test in healthy volunteers
NCT ID NCT06768619
First seen Jan 09, 2026 · Last updated May 16, 2026 · Updated 18 times
Summary
This study checked if a new generic version of eltrombopag (a drug that helps increase low blood platelets) works the same as the original brand-name drug. It involved 36 healthy adults in China who took both versions after a meal. The goal was to see if the generic is a safe and effective alternative for people with thrombocytopenia.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THROMBOCYTOPENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Changchun University of Traditional Chinese Medicine Affiliated Hospital
Changchun, Jilin, 130021, China
Conditions
Explore the condition pages connected to this study.